Article Text

other Versions

PDF
Research
Development and validation of a new disease severity index: the Inflammatory Bowel Disease Index (IBDEX)
  1. Laith Alrubaiy,
  2. Phedra Dodds,
  3. Hayley Anne Hutchings,
  4. Ian Trevor Russell,
  5. Alan Watkins,
  6. John Gordon Williams
  1. College of Medicine, Swansea University, Swansea, UK
  1. Correspondence to Dr Laith Alrubaiy, College of Medicine Swansea University, Room 220, Grove building, Swansea SA2 8PP, UK; l.alrubaiy{at}swansea.ac.uk

Abstract

Objective To develop, validate and apply a generic clinical severity index applicable to all adult patients with inflammatory bowel disease (IBD).

Design A review of the literature and an expert focus group consultation were carried out in order to draw out relevant items from existing literature. The new index was called the IBD Index (IBDEX). Standard psychometric analysis was carried out. The construct validity was assessed against biochemical markers, clinical and endoscopic indices. The new index was completed again within 6 weeks to check responsiveness and reproducibility.

Results IBDEX was used to assess 255 adult patients with IBD (125 with Crohn’s disease and 130 with ulcerative colitis), and 64 patients were re-evaluated within 6 weeks. It had good internal consistency (Cronbach's α=0.79) and correlated very well with the Harvey Bradshaw Index (r=0.94), the Simple Clinical Colitis Activity Index (r=0.92), the Mayo Clinic Index (r=0.87) and the Simple Endoscopic Score (r=0.76), all with p values <0.05. IBDEX had a moderate but positive correlation with C reactive protein (r=0.51) and erythrocyte sedimentation rate (r=0.36) p values both <0.05. The test–retest reliability was good (intraclass correlation coefficient 0.97) and responsiveness ratio was 2.27.

Conclusions IBDEX is the first properly validated Clinical Disease Severity Index in IBD. Our results showed that it is valid, reliable and reproducible and has the potential to be used in clinical practice.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.